The U.S. Food and Drug Administration has rolled out a new AI-powered safety monitoring system that can process millions of consumer complaints in real time, identifying possible concerns with beauty products before they go viral on TikTok.
As part of its new Adverse Event Monitoring System (AEMS) — an initiative that aims to improve the monitoring of “adverse events” or reports of product issues — the federal agency has adopted ThinkTrends’ agentic Document AI platform.
The FDA's new initiative aims to identify safety concerns and detect clusters of problems with regulated products (including cosmetics, drugs, foods, and medical devices) faster, earlier, and more rigorously.
The new platform replaces divided reporting systems with a unified, real-time monitoring structure designed to process 6-7 million adverse event reports per year. It aggregates consumer complaints, clinical reports, and manufacturer data.
Historically, cosmetic products have been under-monitored compared to other categories. With the new system, negative reactions such as irritation, burns, discoloration, or hair loss can be flagged instantly.
The agency intends for the new system to expedite more rapid product recalls or warnings, and shorter timelines between consumer complaints and regulatory action.
For beauty manufacturers, this move signals further adoption of AI in the industry as it becomes critical for safety monitoring, ingredient risk prediction, and regulatory compliance.